Stem Cell Therapy Market Size is Estimated to Increase USD 44.5 … – GlobeNewswire

New York, April 11, 2023 (GLOBE NEWSWIRE) -- Market.us research reveals that The global stem cell therapy market size was estimated at USD 11.1 billion in 2022 and is expected to reach around USD 44.5 billion by 2032, poised to grow at a compound annual growth rate (CAGR) of 15.3% during the forecast period 2022 to 2030. Stem cell therapy is used to transplant stem cells; in this therapy, stem cells are changed by chemotherapy. Stem cell therapy contains types like Hematopoietic Stem Cells (HSCs), Mesenchymal Stem Cells (MSCs), Skin Stem Cells (SSCs), and Neural Stem Cells (NSCs). Chemotherapy act as an immune system to face disorders linked to blood or cancer, such as multiple myeloma, neuroblastoma, lymphoma, and leukemia. The cost of each stem cell therapy method can vary between 5,000$ and 50,000$.

Identify key trends, drivers, and challenges in the stem cell therapy market, which will help vendors improve their strategies to stay ahead of their competitors. View our PDF Sample Report - https://market.us/report/stem-cell-therapy-market/request-sample/

Key Takeaway:

The stem cell therapy market increased owing to a lot of investment in stem cell research, various clinical trials related to stem cell therapy, and an increasing number of cell therapy production facilities. Several cell therapy clinical trials were done during the epidemic due to the various benefits of stem cell therapies.

Factors affecting the growth of the Stem Cell Therapy industry?

There are several factors that can affect the growth of the neonatal intensive care respiratory devices industry. Some of these factors include:

Interested to Procure the Data? Inquire here at -https://market.us/report/stem-cell-therapy-market/#inquiry

Top Trends in Global Stem Cell Therapy Market

The global cancer load is increasing. Hence, cancer therapies must be updated with regional and national priorities. Breast, lung, cervical, colorectal, and thyroid cancers are common among women. However, lung cancer and prostate cancer are the more frequent among men which, acquired a share of 33% of male cancer.

A stem cell transplant is a treatment for cancer types such as leukemia, neuroblastoma, multiple myeloma, or lymphoma types. Autologous transplants are favored in the cases such as leukemia, testicular cancer, multiple myeloma, lymphomas, and neuroblastoma. Autologous and allogeneic stem cell transplants can both be used for cancer treatments.

Regional Analysis

North America dominated the market share of the global stem cell therapy market, with 35% of this market in 2022. The most recent advanced technologies, considerable governmental & private investment, and economic expansion help to benefits the market region. The presence of the latest research infrastructure, rising R&D efforts to form chronic diseases therapeutic choices, and ordinary clinical trials review process for driving the market elements in the region. Key research organizations and market suppliers located in the United States receive large funding. Various projects in the region's pipeline are increasing consumer demand.

Due to an increase in the need for stem cell therapy and a rising prevalence of chronic and neurological diseases, Europe acquired the second-highest market share. The cell therapy in Asia-Pacific market growth is increasing at the highest growth rate because of its fast growth and several companies arrival in APAC. Moreover, the APAC region's increasing use of stem cell therapy and rising cancer dominance are projected to stimulate market expansion.

For more insights on the market share of various regions - Download a Sample Report

Scope of the Report

Market Drivers

The efficient treatment demand is increasing due to the rising chronic disease rate. In the COVID-19 epidemic, chronic diseases such as heart disease, cardiovascular disorder, cancer, neurological disorder, stroke, and respiratory illnesses place a big stress on society. Four of the ten adults have greater than two chronic diseases, and six of ten adults have at least one chronic disease. These show how diseases are dominating as well as how nicely they are managed. Clinical trials are expected to raise stem cell demand during the forecast period.

Market Restraints

Although research on stem cells is very promising for the medical sector, its expansion is restrained due to ethical issues by a regulatory bodies. The devastation of the human embryonic stem cell is the main issue that might have foiled the development of stem cell research.

Market Opportunities

The banking of stem cells need is rising as the number of chronic disorders and genetic abnormalities has increased. An increasing firm has stepped into the stem cell banking sector due to rising public awareness of stem cell therapy. To boost sales and market for stem cell therapy, adult stem cells, which are genetically programmed, are using embryonic stem cells called pluripotent stem cells.

Grow your profit margin with Market.us - Purchase Stem Cell Therapy Premium Market Report athttps://market.us/purchase-report/?report_id=12272

Report Segmentation of the Global Stem Cell Therapy Market

Cell Source Insight

The largest market share was dominated by adipose tissue with 34% market share in 2022. Because source of this cell is used in adipose tissue, which is a specialized connective tissue containing lipid-rich cells known as adipocytes. These adipocytes are mainly discovered in the skin and deposit among the muscles, intestines membrane folds, inside the intestines, near the heart, and other places. Moreover, the global stem cell therapy market share depends on cell source types segmented into IPSCs, neural, PPSCs, embryo/cord, adipose tissue, and bone marrow.

Type Insight

The global stem cell therapy market is growing because the largest market share was occupied by the allogenic segment, with a 74% market share in 2022, owing to its increasing incidence of cancer and other related disorders. The global stem cell therapy market share is based on the type segregated into allogenic stem cell therapy and autologous stem cell therapy. According to the WHO, children of ages 0 to 19 are diagnosed with almost 300K new cases of cancer annually. In 2022, there will be 21 million new cases of cancer, according to estimates. This puts a strain on the global healthcare system and increases the demand for cancer treatments that are efficient anywhere in the world.

Application Insight

The largest market share was dominated by the diabetes segment, with a 28% market share in 2022. Because 450 million people are infected by diabetes across the globe, from WHO report. Diabetes is normal in several countries for individuals of low and medium incomes. The global stem cell therapy market is based on applications segmented into cardiovascular, diabetes, cancer, musculoskeletal disorders, and gastrointestinal diseases. Furthermore, the diabetes segment, also called diabetes mellitus of metabolic disease that is infested when blood glucose levels are too high. Over time period, diabetes disorder can cause a lot of harm to the kidneys, eyes, blood vessels, heart, and eyes.

End User Insight

The largest market share was dominated by the hospitals & clinics segment, with a 28% market share in 2022 because of the rising occurrence of skin conditions like acne. The global stem cell therapy market is based on end-user types segmented into hospitals & clinics, academic & research centers, ambulatory surgical centers, and other end users.

Drivers and challenges have an impact on market dynamics and can impact businesses. Find some insights from a sample report: https://market.us/report/stem-cell-therapy-market/request-sample/

Market Segmentation

By Cell Source

By Type

By Application

By End User

By Geography

Competitive Landscape

With the presence of many local and regional players, the market for global stem cell therapy market is fragmented. Market players have intense competition from prominent key players, mainly those with big recognition of the brand and high networks for distribution. Companies have started various expansion strategies to gain a top spot in the market, such as partnerships and product launches.

The competitive landscape of the market has also been examined in this report. Some of the major players include

Recent Development of the Stem Cell Therapy Market

Browse More Related Reports:

About Us:

Market.US(Powered by Prudour Pvt Ltd) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicatedmarket research report-providing firm. Market.US provides customization to suit any specific or unique requirement and tailor-makes reports as per request. We go beyond boundaries to take analytics, analysis, study, and outlook to newer heights and broader horizons.

Follow Us On LinkedIn Facebook Twitter

Our Blog:

Read more from the original source:
Stem Cell Therapy Market Size is Estimated to Increase USD 44.5 ... - GlobeNewswire

Regenerative Medicine Market Investments, Share and Revenue … – GlobeNewswire

Jersey City, NJ, April 12, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "GlobalRegenerative Medicine Market Size, Share & Trends Analysis Report By Product (Therapeutics, Primary cell-based therapeutics, Stem Cell & Progenitor Cell-based therapeutics), By Therapeutic Category (Dermatology, Musculoskeletal, Immunology & Inflammation, and Oncology)- Market Outlook And Industry Analysis 2031"

The global Regenerative Medicine market is estimated to reach over USD 183.08 billion by 2031, exhibiting a CAGR of 15.02% during the forecast period.

In recent year, it has been determined that regenerative therapies can uniquely change the underlying pathological processes. Trial-stage regenerative medicines offer promising treatments for particular chronic diseases with unmet medical needs. Novartis announced the release of T-ChargeTM in December 2021, a next-generation CAR-T platform that would be used for cutting-edge investigational CAR-T cell treatments.

Free PDF Report Brochure @https://www.insightaceanalytic.com/request-sample/1687

The development of gene-based treatment, which uses targeted DNA delivery as a drug to combat numerous illnesses, results from significant effects in molecular therapeutics. With the restoration of gene function, gene therapy holds great promise for treating cancer and type 1 and type 2 diabetes. Gene-based medicines treat patients with conditions such as cancer, oncology, infectious diseases, cardiovascular disorders, monogenic diseases, genetic disorders, ophthalmological indications, and central nervous system illnesses. These elements have helped the market for regenerative medicine expand.

Recent Developments:

In April 2022, Obecabatagene autoleucel, a CD19-directed autologous chimeric antigen receptor T therapy being investigated in the ongoing FELIX Phase 2 study of leukaemia, has been given the Regenerative Medicine Advanced Therapy designation by the U.S. Food and Drug Administration (FDA). This was announced by Autolus Therapeutics plc.

List of Prominent Players in the Regenerative Medicine Market:

Get Customized Report @https://www.insightaceanalytic.com/customisation/1687

Regenerative Medicine Market Report Scope:

Market Dynamics:

Drivers- The ability of adult stem cells to proliferate or self-renew forever and to develop all the cell kinds of the organ from which they originate has propelled research into these cells, with the potential to regenerate the complete organ from a few cells. No embryo must be destroyed in order to produce adult stem cells. Furthermore, medical research on stem cells has been thoroughly examined and attracted much attention. ExCellThera Inc. and Ossium Health recently announced a partnership to explore and advance opportunities to use adult stem cells from deceased donors from Ossium Health's first-ever bone marrow bank in combination with ExCellThera's ECT-001 cell expansion and rejuvenation technology. This collaboration will take place in April 2021. These kinds of developments are anticipated to accelerate market expansion.

Challenges:The market for regenerative medicine is projected to be hampered by a lack of information and moral considerations surrounding the usage of embryonic stem cells for research and development. Since cell therapy is a crucial component of regenerative medicine, it has a significant impact on the market growth rate. One of the leading market inhibitors may be the high cost of investment, which might be followed by problems with assay sensitivity, robustness, and reproducibility; the challenge of culture/propagation; and finally, the challenge of handling.

Regional Trends:Due to the presence of big players, the rapid advancement of technology, significant investments in stem cell and oncology research, and the presence of major players, North America is predicted to have the largest revenue share. The largest market in North America is the United States. In the U.S., numerous stem cell therapies are increasingly being used to treat a growing number of ailments like cancer and diabetes. According to the Heart Disease & Stroke Statistics Fact Sheet 2020, congenital heart abnormalities are predicted to affect at least 40,000 infants annually in the United States.

Enquiry Before Buying @https://www.insightaceanalytic.com/enquiry-before-buying/1687

Segmentation of Regenerative Medicine Market-

By Product-

By Therapeutic Category-

By Region-

North America-

Europe-

Asia-Pacific-

Latin America-

Middle East & Africa-

About Us:

InsighAce Analytic is a specializing in market research and consulting services that helps in building business strategies. Our mission is to provide high quality insights with using data analytics techniques and visualization tools that drives the disruption and innovation in market research industry. Our expertise is in providing syndicated and custom market intelligence reports with in-depth analysis and key market insights in a timely and cost-effective manner.

Follow Us @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/

Subscribe Our Exclusive Newsletters @ https://www.linkedin.com/newsletters/latest-market-research-reports-6929319878155739136/

Read the original here:
Regenerative Medicine Market Investments, Share and Revenue ... - GlobeNewswire

Bourbonnais toddler beats leukemia with stem cell transplant – Kankakee Daily Journal

While watching 3-year-old Mads Pomranky excitedly play on a Tuesday afternoon with his 1-year-old sister, Valen, one would never guess the difficult health struggles hes overcome.

At 5 months old, Mads was diagnosed with juvenile myelomonocytic leukemia, a rare cancer of the blood that affects young children. The diagnosis eventually turned to acute myeloid leukemia and was treatable only through a transplant from a stem cell donor.

For parents Jennifer and Derrick Pomranky, of Bourbonnais, they made the immediate decision to approach the challenge with positivity, designating their son Mighty Mads.

Its pretty difficult to watch your little baby go through this, Jennifer said. I feel like right away, we both had the mentality of, Hes gonna get through this, were gonna get through this.

We got through it one day at a time, added Derrick.

As an infant, Mads was often sick with congestion or runny nose. It was a pediatrician, Dr. Josefina Batista at Riverside Healthcare, that noticed his spleen was enlarged. Further testing would show his red blood cell count being low while his white cell count was high. These red flags led to the eventual leukemia diagnosis.

His pediatrician caught it so fast that we had time on our side that they could pinpoint the diagnosis and take their time with the chemo and wean him into it a little bit, said Jennifer while flipping through a book the family made for Mads donor. The book details Mads journey with cancer and treatment.

The book documents that Mads had six rounds of chemo, 83 doses of chemo, 31 blood transfusions, 31 platelet transfusions, 11 bone marrow biopsies, five spinal taps with chemo, two skin biopsies and one cryo transfusion.

His parents noted they were lucky in the search for a donor, as Mads health care team found a 10 out of 10 match through the stem cell/bone marrow transplant registry, DKMS.

The donation was from a young woman, Kaelynn Speed, out of Cincinnati.

Weve been an advocate for [DKMS], Jennifer said, noting that the DKMS shirts her kids were wearing were given to the family when they first met Speed through a donor meeting facilitated by the donor registry.

By the time doctors were able to begin providing transplant care to Mads then 13 months old the world was in the throes of COVID-19. As a result, Speeds cell donation had to be frozen for two weeks before being administered to Mads.

Mom Jennifer said that the process took about an hour and was similar to a blood transfusion.

Now, Mads has to have bloodwork done every three months to make sure everything is on the up and up. Additionally, he does a survivorship follow up at Comer Childrens Hospital, where he had his treatments.

Hes doing great. Hes very rambunctious and a normal toddler, said Jennifer.

Born May 16, 2019, Mads now has double the annual celebrations first, his birthday, and second, what his parents have dubbed his rebirthday on June 17, which is when he had the transplant.

Before and after transplant, he was really sick, Derrick said. So that was a bad time.

When he was going through all of it, he missed a lot of his milestones. He was basically reborn again, added Jennifer.

LIFE AND DEATH

The family still keeps in touch with Speed and her family; they received her information on the one-year anniversary of Mads transplant and set up a Zoom meeting. The families met in person last summer.

Shes the nicest person, she was only 19 when she signed up [to donate], Jennifer said. Derrick added that shes studying nursing.

Between work and two toddlers, the Pomranky parents certainly have their hands full, but they always make time to encourage people to sign up to be stem cell and/or bone marrow donors.

You could potentially save a life, Jennifer said. Its a matter of life and death, literally.

Excerpt from:
Bourbonnais toddler beats leukemia with stem cell transplant - Kankakee Daily Journal

Invasive aspergillosis: Symptoms and more – Medical News Today

Aspergillosis is an infectious disease that occurs due to a common type of fungus, or mold, called Aspergillus. A type of aspergillosis called invasive aspergillosis particularly affects people with weakened immune systems.

Most individuals breathe Aspergillus spores daily and do not develop any health effects.

However, people with compromised immune systems, such as those who have had an organ transplant or are undergoing chemotherapy treatment, may be at greater risk of developing aspergillosis.

The disease usually affects the lungs but can spread to other areas of the body.

This article looks at invasive aspergillosis and its symptoms, diagnosis, outlook, and more.

Aspergillus mold is common indoors and outdoors and can cause infection in the sinuses and lungs of immunocompromised people.

If the infection spreads to the rest of the body, outcomes are very unfavorable and include death.

Experts do not know the extent of aspergillosis in the United States, as it is not a reportable infection. However, according to a database of insurance claims, there were almost 15,000 hospitalizations for this diagnosis in the U.S. in 2014.

That said, the number of people with aspergillosis has likely increased since then.

Invasive aspergillosis is less common than the milder, allergic forms of the disease. It is the most common fungal infection in people who have had stem cell treatment. It is also the second most common in those who have received solid organ transplants.

Invasive aspergillosis usually occurs in people with weakened immune systems who often already have other medical conditions. Therefore, it can be difficult to differentiate between the symptoms of the infection and those of the underlying illness.

The symptoms of invasive aspergillosis may include:

Types of invasive aspergillosis include:

Other types of aspergillosis include:

A person can develop aspergillosis by breathing in Aspergillus spores, which are common in indoor and outdoor environments.

Most people will not get sick from breathing the spores, but those with weakened immune systems are at greater risk of infection.

People at risk of invasive aspergillosis include individuals with weakened immune systems, such as those who have received:

Additionally, hospitalized patients with severe influenza and those with HIV are at risk of invasive aspergillosis.

To diagnose aspergillosis, a doctor may examine a persons medical history and risk factors and ask questions about their symptoms.

They may perform a physical examination and several laboratory tests. These may include:

Doctors may treat invasive aspergillosis with several different antifungal medications.

These may include:

Where possible, doctors may also decrease or discontinue immunosuppressive medications to help treat invasive aspergillosis.

Because Aspergillus spores are common in the environment, it is difficult for people to avoid breathing them in.

Experts recommend those with weakened immune systems take certain measures to protect against the fungus. However, these actions may not prevent aspergillosis.

Preventive measures may include:

The outlook for invasive aspergillosis is generally unfavorable.

The mortality rate of invasive pulmonary aspergillosis is about 20% six weeks after diagnosis, despite treatment with antifungal medications.

The mortality rate reaches close to 100% once the infection has spread to the central nervous system.

Most people safely breathe Aspergillus spores every day, as these are common in indoor and outdoor environments.

However, those with weakened immune systems may be at risk of developing health problems from breathing microscopic amounts of the fungus.

In immunocompromised people, such as those undergoing chemotherapy or those who have had stem cell or organ transplants, invasive aspergillosis may affect the lungs and sinuses. This can cause symptoms such as shortness of breath and coughing up blood.

The disease may spread to other areas of the body and is often fatal once it reaches the central nervous system.

Treatment for invasive aspergillosis typically includes the use of antifungal medication.

Doctors may advise high risk individuals who are immunocompromised to take measures that may help prevent aspergillosis. These approaches include wearing protective equipment and clothing, testing, and taking antifungal drugs.

See the article here:
Invasive aspergillosis: Symptoms and more - Medical News Today

How artificial intelligence can help primary care doctorsand their … – Medical Economics

Two letters. Theyre enough to give your patients more anxiety than any treatment, test or injection. A recent survey by the Pew Research Center shows it: Sixty percent of Americans said they would be uncomfortable with their provider relying on artificial intelligence (AI) in their own health care. But when used responsibly, artificial intelligence can help primary care doctors expand their care while cutting costs in their practices. And patients will notice the difference tooeven if they dont realize the technology behind their improved experience is the result of those dreaded two letters.

Informed patients, informed doctors

What really scares patients is the idea of AI performing the skilled work of doctors. The fact is, however, we are a long way from AI replacing doctors. Nor will AI replace office staff. But we are now at a point where AI can start to address the communication issues doctors face in their practices.

Patients say they dont want AI making health care decisions for them based on its interpretation of their conditions, but AI can help patients navigate through the treatment process and get them information a lot faster. For example, doctors can use AI and chatbots in their patient engagement strategy to better understand their patients, send them personalized information that is tailored to their treatment journey, and create interactions that are relevant to their personal needs.

AI has numerous applications for primary care physicians who are looking to manage their patients health proactively, Jonathan Sachs, MBA, vice president and chief experience officer for Robert Wood Johnson University Hospital, told me. AI can unlock a physicians ability to understand a patients needs beyond their 15-minute office visit by helping that physician make sense of longitudinal data from multiple sources such as wearables, at-home biometric technology, and internet of things devices.

Interactive messaging

As Googles chief health officer Karen DeSalvo, M.D., MPH recently noted, the future of health is consumer-driven. AI can help doctors be ready for the shift by improving the way they and their staff communicate with their patients.

Many practices are adopting advanced communications platforms to help streamline their workflow and patient interactions. AI and machine learning will take these platforms beyond simple appointment reminders to create better patient experiences.

AI can send relevant content to the patient at the time they need it the most, which leads to patients who are better educated, more comfortable, more confident, and more engaged in meaningful conversations about their health. The result is better outcomes, and ultimately more patients and cases.

AI Is already working in health care

AI is already helping doctors do their jobs better and more efficiently. Patient diagnostics is one area where we see this already. AI can help doctors ensure that patients who need care most urgently are treated first. AI can also help staff keep track of patients in nursing homes by monitoring their conditions based on data, which takes some of the sting away from nursing shortages. It can also detect disease by analyzing data and advance treatment through machine learning.

In private practices, AI is ready to step in and help with eligibility checks, prior authorizations, insurance claims, referrals, and billing. The immediate benefit of the digital transformation to primary care doctors in their practices, however, is the technologys ability to boost patient engagement and adherence.

Also, imagine the day when the majority of your scheduling is done by a patient interacting with AI in your practice. Integrating AI technology with practice management systems will make that possible. Appointments will be made and changed all while your front office staff is checking in a patient. The result is a superior patient experience while doctors, nurses, and office staff get time back in their days for the tasks that are most important to them.

Easing patients concerns

AI is coming fast and furious, and that is undoubtedly why some of your patients will be apprehensive. The pace of change is exploding. The Wright Brothers first flight was in 1903, but commercial air travel didnt truly take off until decades later. The first human heart transplant was in 1967, while the internet revolutionized the world in a short period of time. And as my great friend Michael Longaker, M.D., co-director of the Stanford Institute for Stem Cell Biology & Regenerative Medicine recently said to me, The pace of change [in fields like] stem cell biology is rising exponentially each year.

Patients will get used to AI in their health care. It wasnt long ago that consumers were afraid to put their financial information online to complete a transaction. Now online shopping is so common that malls are half-empty even during the holiday season. Its going to take a little time until AI proves to be more effective, but in the present we can look for ways to help patients navigate information better. The right information at the right time makes a difference.

Jock Putney is the founder and CEO of WUWTA, an experience and engagement platform designed to help practices engage patients in their care and create better treatment outcomes.

Read more:
How artificial intelligence can help primary care doctorsand their ... - Medical Economics

Patients have renewed interest in STI exams after post-Covid spike – Medical Economics

Primary care physicians are being urged to encourage their patients to take a renewed interest in their sexual health after a report showed a spike in STI cases following Covid-19 lockdowns in 2022. According to experts, STI screenings were put off during the pandemic as patients prioritized other health care appointments.

The Zocdoc report, released ahead of CDC's STI Awareness Week, shows that patients have started to book more STI appointments in 2023. Zocdoc appointment booking data revealed that bookings in the first half of March 2023 were 26% higher than the same period in 2022.

The report also highlights a demographic divide, with men being more proactive about checking their sexual health than women. Millennials and Gen Z patients booked the most STI appointments, with patients in their 20s booking nearly twice as many appointments as those in their 30s. Meanwhile, seniors (65+) made up less than 1% of the bookings.

Genital warts caused by the Human Papilloma Virus (HPV) were the most common STI issue, accounting for 24% of all bookings. Genital herpes, HIV/AIDS, HPV, and hepatitis were also among the most commonly reported STIs.

Patients in Atlanta were found to be the most proactive about their sexual health, with the highest rate of STI bookings per patient. In contrast, patients in Boston, Charlotte, NC, San Francisco, and Nashville had some of the lowest booking rates.

Primary care physicians are encouraged to promote STI screenings and provide education on safe sex practices to help reduce the spread of STIs. CDC's STI Awareness Week runs through April 15th and provides a timely opportunity for health care providers to engage with their patients on this important issue.

See the original post:
Patients have renewed interest in STI exams after post-Covid spike - Medical Economics

Woman diagnosed with incurable condition after eyes turned completely white – Yahoo News

Kerrys partner plans to walk the equivalent of a half marathon with Kerrys weight on his back to raise money for treatment abroad (Collect/PA Real Life)

A woman who lost her father to suicide and was diagnosed with a brain tumour in the space of six months, having seizures up to three times a month, has taught her 10-year-old son how to call 999 and says shes only still alive for (her) kids sake.

Kerry Warburton, 35, who lives in Gainsborough, Lincolnshire, with her partner, Craig Kirkham, 36, their son, Ethan, 10, and their daughter, Ellana, 10 months, landed her dream job as a teaching assistant in December 2019,but in April 2020 she began having seizures where her eyes would turn completely white and she could no longer work.

On top of this, in July 2020 Kerrys dad died by suicide, and in January 2021 doctors found a tumour in her brain, which was causing her seizures.

One month later, doctors tried to remove her tumour by performing an open craniotomy, which made her lose her speech, and while in hospital she contracted Covid and was quarantined for 12 days partnerCraig thought she was on deaths door and doctors wereseconds away from turning off her life support, but she recovered.

Things were beginning to look up Kerry fell pregnant with her second child, Ellana, but after resuming treatment, a follow-up MRI scan revealed that her brain tumour was at stage four.

Now, Craig is planning to walk the equivalent of a half marathon to raise money for stem cell therapy which could prolong Kerrys life by three to five years.

I was at an all-time low when receiving treatment, especially after losing my dad Im only still alive now for my kids sake, Kerry said.

In December 2019, Kerry finally landed her dream job, as a teaching assistant, after going back to college as a mature student.

But in April 2020, Kerry began to have seizures, which was the first warning sign for her terminal brain tumour.

Her partner Craig said: She was shaking like mad, and her eyes rolled back in her head, and I saw foam and blood come out of her mouth.

I didnt know what the hell was going on. I was so scared, and I thought she was dying.

Story continues

The whole bed was shaking, and I thought we were having an earthquake or something.

(PA Real Life)

I had no clue what to do I was trying to push her head back into the pillow to stop her shaking, and her eyes were completely white.

Craig quickly called an ambulance, and Kerry was taken into Lincoln Hospital for tests and an MRI scan.

But Kerry was not diagnosed with anything and continued to have seizures up to three times a week, while her father died by suicide in July 2020.

Kerry said: I hit rock bottom, they took me off my seizure meds because it can cause low moods, and my seizures got worse I was having them twice a week.

In January 2021, she received more devastating news she had a five-by-five-by-five centimetre tumour in her brain.

Just a few weeks later, in February, Kerry had an open craniotomy, and was told she had stage two brain cancer,which caused her to have aphasia when a person has difficulty with their language or speech.

She explained: I lost my speech completely, it was horrible.

It was so hard for me because I wanted to speak I could speak clearly in my mind, but I couldnt get it out.

(PA Real Life)

When in hospital, she contracted Covid-19 and was quarantined for 12 days.

Craig said: I thought she was on deaths door. It was so scary they were seconds away from putting her to sleep.

It was terrifying because you couldnt go and see her.

I didnt sleep at all Id message her and check her WhatsApp constantly just to check she was alive.

Once out of hospital, Kerry found out she was pregnant and in June 2022 she gave birth to her second child, Ellana.

Just two months later, she had another MRI scan which concluded the brain tumour was terminal and stage four.

Craig said: It was scary as hell we were all happy, we had the baby, and then we were thrown back into the deep end again.

We had to travel for 55 miles for treatment again, for six weeks every single day.

Since October 2022, Kerry has been receiving radiotherapy and chemotherapy, which has caused her to lose her hair and put on over two stone.

She said: It affects my confidence I dont want to leave the house.

Kerry continues to have seizures, but they have gone down to three per month, and has even had to teach her 10-year-old son Ethan how to call an ambulance.

She said: Were scared to death that I might have a seizure when Craig is at work, so weve taught him how to call an ambulance.

Weve had to give him counselling at school to cope with me being so ill.

It was hard to teach him how to do it,I was petrified, and his school have helped.

I know it must be horrible for my son, I blame myself for him getting upset about it.

To raise money for stem cell therapy, which could extend Kerrys life by three to five years,Craig has set up a GoFundMe and plans to walk from Lincoln Castle to his house, which is the equivalent of a half marathon, with Kerrys weight, 12 stone, on his back.

Craig said: Gravity will be trying to pull me into the ground just like this tumour is trying to put her in the ground, but we are going to defy both.

Kerry added: It would just be wonderful to have the treatment, and to not worry my son anymore.

To find out more about Craigs fundraising, visit http://www.gofundme.com/f/kerry-the-white-knight.

See the original post here:
Woman diagnosed with incurable condition after eyes turned completely white - Yahoo News

Memphis Grizzlies provide details on why Steven Adams hasn’t been cleared for NBA playoffs – Yahoo Sports

The Steven Adams injury and timeline has left fans searching for answers.

A report from ESPN's Adrian Wojnarowski said that Adams is "unlikely to return" for the NBA playoffs. This came a week after Memphis Grizzlies coach Taylor Jenkins noted that Adams was beginning a reevaluation period where the team hoped he'd be able to return soon.

The Grizzlies practiced on Tuesday. Adams was at practice shooting free throws

"It's pretty confirmed he's most likely out for the playoffs," Jenkins said. "We don't have definitive words on what the next steps are. It's been an ongoing process the last couple of weeks. I think there's more dialogue still this week with doctors involved. We want to make sure Steven's in a good place."

KENNEDY CHANDLER: Kennedy Chandler tweets thanks to Memphis Grizzlies after release

ALL-AROUND GAME: What Grizzlies' Desmond Bane learned watching Danny Green, Devin Booker, Klay Thompson

GIANNOTTO: Memphis Grizzlies: Glory vs. LeBron James, Lakers or path of least resistance | Giannotto

Adams initially sprained his right PCL in January. He was expected to return in early March, but he needed a stem-cell injection that sidelined him another four weeks.

That lined Adams up for a potential reevaluation at the end of the regular season. When the Grizzlies signed Kenneth Lofton Jr. to a standard contract, it felt like an indicator of Adams' playoff status and the lack of frontcourt depth, but the Grizzlies didn't issue an official update.

"We thought we were making headway with the process and all that, but each evaluation we had with the doctors kind of revealed it's not progressing like we need it to. ... No setbacks, no reinjuries, it was just not progressing to a level. Obviously some unfortunate news, but that's why we're going to try to do everything possible to try to get the best decision possible for him," Jenkins said.

Story continues

The Grizzlies haven't ruled out surgery as an option for Adams. Jenkins said that everything remains on the table.

Xavier Tillman Sr., Jaren Jackson Jr. and Santi Aldama are expected to get the bulk of minutes at power forward and center. Aldama didn't play in the final two regular season games due to left elbow soreness, but Jenkins called it precautionary.

Aldama was a full participant in practice on Tuesday and wore a compression sleeve on his left arm.

This article originally appeared on Memphis Commercial Appeal: Steven Adams: Memphis Grizzlies give injury report for NBA playoffs

See the original post:
Memphis Grizzlies provide details on why Steven Adams hasn't been cleared for NBA playoffs - Yahoo Sports

Platelet-Rich Plasma Market Is Anticipated To Increase At A Steady CAGR of 12% by 2031 | Fact.MR – Yahoo Finance

FACT.MR

Fact.MRs latest report on platelet rich plasma market analyzes opportunities, trends, and threats affecting growth in the market. It offers an in-depth analysis of the market in terms of product type, application, and end users. The study also reveals interesting information about strategies adopted by market leaders.

Rockville , April 11, 2023 (GLOBE NEWSWIRE) -- The global platelet-rich plasma market reached US$ 400 million in 2020. From 2021 to 2031, global platelet-rich plasma demand will thrive at 12% CAGR. Total market valuation at the end of 2031 is likely to reach US$ 1.5 billion.

Increasing prevalence of sports injuries incidence and chronic orthopedic conditions is a key factor driving the platelet-rich plasma market. Similarly, rising number of cosmetic and surgical procedures performed globally will elevate demand.

A concentrate of platelet-rich plasma protein obtained from whole blood is called platelet-rich plasma or PRP. It is also referred to as autologous conditioned plasma. It contains different growth factors and cytokines that can trigger healing of joints and soft tissues.

For Critical Insights on this Market, Get A Free Sample Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=170

In recent years there has been a significant increase in the demand for platelet-rich plasma. This is due to its use in applications such as tissue regeneration, scar revision, wound healing, alopecia, etc. PRP is also showing promising results in the treatment of conditions such as osteoarthritis.

Hence, increasing cases of sports injuries, orthopedic diseases, and musculoskeletal disorders will fuel PRP demand through 2031. For regenerative medicine, PRP is a significant source of personalized products for each patient that support wound healing and the repair cascade.

PRP has become a magical potion for flawless skin and hair. It is gaining immense traction in cosmetic surgery and hair loss treatments. PRP injections are being increasingly used to treat hair loss conditions such as alopecia.

Story continues

In 2020, PRP use in cosmetics increased by around 25% over the past four years, according to the American College of Plastic Surgeons report. Rising usage in cosmetics will therefore continue to boost PRP sales revenues through 2031.

Several studies are presently being conducted to assess the effectiveness of PRP in therapeutic areas such as disc herniation and hair loss. It is believed that PRP therapy can rejuvenate skin and reduce wrinkles.

Although this therapy cannot replace certain critical conventional treatments, it can reduce the economic cost of standard medical procedures.

In hair transplantation, PRP binds to growth factors and increases the proliferation of human dermal papilla cells, resulting in hair follicle formation and maintenance.

Platelet-rich plasma has also gained wider popularity in plastic surgery. Properties such as ease of use, inexpensive manufacturing using patient cells, and little or no risk of side effects are the main reasons for the increasing adoption of PRP in therapy.

Based on product type, pure platelet-rich plasma kits segment dominates the global market. This is due to various advantages of pure-PRP kits which include enhanced wound healing and tissue repair.

Regionally, North America will continue to lead the global PRP market. This is due to increasing cases of sports injuries and orthopedic disorders. Similarly, development of PRP-based therapies, rising interest in personalized medicine, and high sourcing from end-users such as hospitals and clinics will boost North America market.

Key Takeaways from the Market Report:

Global platelet-rich plasma sales revenue will increase at 12% CAGR during the forecast period.

Based on product type, pure platelet-rich plasma kits segment held around 50% revenue share in 2020.

Based on end user, hospitals segment is set to thrive at 10% through 2031.

India platelet-rich plasma market will exhibit a CAGR of 8% from 2021 to 2031.

In the United Kingdom, platelet-rich plasma demand is likely to surge at 8% CAGR.

The United States market will experience a 9% CAGR throughout the projection period.

Growth Drivers:

The rising incidence of orthopedic and sports injuries coupled with increasing acceptance of PRP as an effective treatment option will drive the market.

Rise in surgical and cosmetic procedures will generate high demand for PRP treatments.

Increasing awareness about PRP and its potential advantages will boost sales revenue

Technological advancements in the PRP devices supported by new product launches will foster market development

Growing popularity of plasma-rich protein therapies for treating various conditions will create new growth prospects

Restraints:

High cost of PRP procedures and various side effects associated with PRPs are limiting market expansion.

Low awareness about PRP in several regions of the world might restrain market development.

Get Customization on this Report for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=RC&rep_id=170

Competitive Landscape:

Key players are focusing on implementing various strategies to expand their product offerings and strengthen their geographic footprints. They are spending large amounts on research and development.

For instance,

In February 2020, all assets of Cellmedix Holdings LLC which includes the Centrepid Platelet Concentration System were acquired by EmCyteCo. This expanded the business's product portfolio.

In September 2021, Royal Biologics Maxx-PRP Concentration System received FDA 510K approval.

Key Companies Profiled by Fact. MR

Arthrex, Inc.

Johnson & Johnson

Zimmer Biomet Holdings, Inc.

Exactexh, Inc.

Stryker Corporation

Terumo Medical Corporation

Biotest Aktiengesellschaft

CSL Ltd.

More Valuable Insights on Platelet-Rich Plasma Market

In the report, significant growth approaches such as acquisitions and mergers, cooperation, and partnerships are operated. The reports provide an in-depth report of the opportunities and growth drivers anticipated to boost the expansion of the platelet-rich plasma market through segmentation as follows:

Product Type:

Platelet-Rich Plasma Instruments

Pure Platelet-Rich Plasma Kits

Leucocyte- Rich Platelet-Rich Plasma Kits

Platelet-Rich Fibrin Kits

Pure Platelet-Rich Fibrin Kits

Application:

Orthopedic Surgery

Cosmetic Surgery

General Surgery

Neurosurgery

Other Surgeries

End User:

Hospitals

Orthopedic Clinics

Dermatology Clinics

Others

Region:

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East & Africa

Buythis Premium Research Report (170Pages, 241 Tables & 87 Figures)https://www.factmr.com/checkout/170

Key Questions Covered in the Platelet-Rich Plasma Market Report

What will be the demand outlook for the platelet-rich plasma market during the forecast period?

Which are the challenges faced in the platelet-rich plasma market?

Which application will lead the growth in the platelet-rich plasma market from 2021 to 2031?

What is the projected market valuation of the platelet-rich plasma market in 2031?

Which are the factors driving the platelet-rich plasma market from 2021 to 2031?

Which end user will generate maximum revenue in the platelet-rich plasma market?

Explore Fact. Mrs Coverage in the Healthcare Domain

Plasma Fractionation Market: The global plasma fractionation market is set to reach a valuation of US$ 65 billion by 2032. Total demand for plasma fractionation will rise at 7.3% CAGR over the next ten years. Rising prevalence of chronic disease and widening usage of immunoglobulins for treating several conditions are driving the market forward.

Plasmapheresis Market: As per Fact.MR, global demand for plasmapheresis is set to increase at 7.4% CAGR through 2032. Total market valuation at the end of 2032 will reach US$ 2.6 billion. Increasing incidence of autoimmune diseases and growing health awareness are key factors driving the plasmapheresis market.

Mycoplasma Detection Systems Market: The global mycoplasma detection systems market size reached US$ 560 million in 2021. Over the next ten years, global mycoplasma detection systems sales will surge at 9.6% CAGR. By the end of 2032, the total market valuation will cross US$ 1.5 billion. Rising emphasis on mycoplasma testing by research and pharmaceutical companies will elevate mycoplasma detection system demand.

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our clients satisfaction.

Contact:US Sales Office11140Rockville PikeSuite 400Rockville, MD20852United StatesTel: +1 (628) 251-1583, +353-1-4434-232 (D)Connect to Author: Mr. Shambhu Nath JhaEmail:shambhu@factmr.com Sales Team:sales@factmr.comFollow Us:LinkedIn|Twitter|YouTube

Read the original here:
Platelet-Rich Plasma Market Is Anticipated To Increase At A Steady CAGR of 12% by 2031 | Fact.MR - Yahoo Finance

When Blood Is a New Alternative Medicine for Pain Relief at Chula … – PR Newswire

BANGKOK, April 11, 2023 /PRNewswire/ --Chula Medicine researchers have successfully published an article on the injection of patient's own platelets rich plasma into the shoulder ligaments resulting in painreduction, heal torn ligaments and restore torn muscles as an alternative to surgery while reducing the side effects of prolonged use of pain medications.

"Pain"is a condition that no one wishes to experience. And when it occurs, people want to heal as soon as possible. This can be achieved through taking painkillers or alternative medical approaches such as acupuncture, massage, using heat compression, etc. But today,Chula Pain Clinic, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society has a new proven treatment for pain derived from the person's own "platelets" to offer.

"Platelet-Rich Plasma (PRP) injectionfor shoulder ligament injuries or "rotator cuff tears" is one of the treatments we have been doing for over 5 years." ExplainsAssistant Professor Marvin Thepsoparn, MD, an anesthesiologist and pain management specialist at the Pain Clinic, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society. "This approach helps to reduce the side effects of painkillers and is very safe because the patient's own platelets and plasma are used to inject back into patient's injury site to stimulate self-repair," Dr. Thepsoparn is discussing how to relieve pain with platelets.

This research was conducted in collaboration with the Orthopaedic Sports Unit of King Chulalongkorn Memorial Hospital to study pain care for people who have suffered injuries from work, sports, and abnormal body movements. These are the causes of muscle injuries and torn ligaments, which can lead to lifelongchronic pain.

"In this study, we compared the efficiency of treatments by performing an MRI of the shoulder of patients who had already received platelet injection for 6 months, and those who did not use this method to treat torn shoulder ligaments. We found that injecting of the concentration of platelets into the shoulder ligaments significantly reduced pain within 1 2 months and also helped repair the tear, resulting in better healing of the ligaments and a reduction in size of the tear. As a result, patients did not have to suffer from chronic pain, avoided surgery, and eliminate the risk of continuously taking painkillers for an extended period."

The concentration of platelets a new option for pain relief

Dr. Marvin explains the two commonnon surgicalapproaches to pain treatment today: medication and non-drug treatment.

1. Pain treatment with standard analgesic drugs that are commonly used include:

2. Pain Management without medication can be divided into two groups:pain intervention procedures such as radiofrequency ablation of nerves, steroid injection and PRP injection. Secondly, physical therapy by Rehabilitation Medicine which can be done in various ways, including shock wave therapy, ultrasound therapy, warm compress, massage, cold compress, acupuncture and music therapy, etc.

"PRP Injection for body regeneration is considered an alternative medicine that has been practiced abroad for over 10 years. Platelets have various substances that the body produces for self-repair. Therefore, platelet injection has been studied both for cosmetics purposes and for pain management in the knees, shoulders, and other organs in the body," explained Dr. Marvin. He added that many hospitals in Thailand now use this approach as an anti-aging medicine.

Blood quality: efficiency for pain relief

Because this method uses the patient's own platelets, the effectiveness of treatment varies depending on the patient's physical condition, age, lifestyle, habits, andblood quality of the individual patient.

"If the patient is strong, exercises enough, or is an athlete, the blood quality will be good, and so is the body repair effect."

Dr. Marvin cited a foreign study of platelet injections which indicated that the effectiveness of platelet injections in body repair would be very effective for patients under the age of 55.

"This method is very safe because it uses the patient's own blood for treatment, so there are no side effects like using conventional painkillers. Often, patients over 60 years old come to seek treatment using this method, and the doctor agreed to do it, but informs the patient that the effects may not be as good as those who are under 55 years old."

"The treatment is done by taking about 15-30 ml of venous blood and then running it through a centrifuge to concentrate the platelets and splitting the plasma and red blood cells. Then take the plasma with platelets to be used for immediate treatment."

Who is PRP not suitable for?

Though very effective, PRP injection is not suitable for all patients, especially the following two groups:

Shoulder ligament problems trending ailments in urbanites

Until recently,Chula Pain Clinichas taken care of many patients suffering from chronic pain caused by shoulder ligament problems.

"We found that shoulder ligament problems are mostly the result of heavy lifting, work related injuries, and sports injuries. These injuries often take a long time to heal and recover from. PRP injections are therefore beneficial for athletes, office workers, and anyone wanting to recover from injuries in a shorter time so that they can get back to work, compete in sports and live a high-quality life as soon as possible," explained Dr. Marvin briefly.

"We atChula Pain Clinichave a comprehensive approach to patient care, where doctors including surgeons, orthopedic specialists in shoulder surgery, and rehabilitation doctors work together to restore the shoulder function." Dr. Marvin explained

"The doctors begin by selecting the appropriate treatment for the best results that can improve the patients' quality of life. If an ultrasound or MRI shows shoulder ligament injury or frozen shoulder and the team diagnoses that surgery is not required nor suitable, exercise would not help alleviated the pain, an PRP injections should be administered. The patient will be referred to receive PRP injections.Most Patients will receive one or at most two injections, and the pain should have expected to decrease by 80 percent. The remaining 20 percent of the pain will go away with time and rehabilitation exercises.

Dr. Marvin further added, "the cost of treatment is around 9,000 baht per session (procedure)."

The Future of Research on Pain Management with Patients' Own Blood

Dr. Marvin explained the progress of clinical research "in medicine, we do not stop researching to help relieve patients from pain and suffering. This research has also been extended to other organs, such asthe study of PRP injections to suppress pain in fused vertebrae (Ankylosing Spondylitis) cases. The study has reached the 50 percent progress milestone, and we are still looking for patients to participate in the study." Dr. Marvin invited those interested to make an appointment at the Chula Pain Clinic to be examined and diagnosed by physicians to see if they have Back pain and if eligible, patients can choose to participate in the study voluntarily, free of charge.

Stop the pain at the Chula Pain Clinic

"Nobody wants to be in pain, but when ill, they need to be healed. Would it be better if the patients don't need to suffer from pain which is a side effect of their long period of treatment and rehabilitation? This is the concept of the Pain Clinic," Dr. Marvin concluded.

Interested parties suffering from rotator cuff pain, or pain in other parts of the body can receive an examination for correct diagnostics and treatments atPain Clinic,17th floor, Phor Por Ror Building, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society during Monday Friday from 8.00 a.m. 4.00 p.m. by making an appointment in advance or by calling +66 2256 5230.

Information Box

Open for volunteers to participate in pain management research project to improve quality of life

Chula Pain Clinic also has two other clinical research projects on pain management to develop better pain relief and pain management options for patients. We are accepting volunteers to participate in the projects, which require patients with physical pain as follows:

Individuals who are interested in taking part in the aforementioned study may request an appointment at Chula Pain Clinic to undergo a pain diagnosis for any disease. If deemed eligible, patients have the option to voluntarily participate in the study and receive treatment free of charged. Those interested in participating in the above study can request an appointment at theChula Pain Clinicfor a diagnosis of pain from any disease. If eligible, patients can choose to participate in the study voluntarily to receive treatment free of charge.

For the full release and more images, please visit: https://www.chula.ac.th/en/highlight/110448/

About Chulalongkorn University

Chulalongkorn University sets the standard as a university of innovations for society and is listed in the World's Top 100 Universities for Academic Reputation, in the Quacquarelli Symonds (QS)World University Rankings 2021-2022.

If you would like more information about this topic, please contact Miss Thanita Wangvanichapan at (+66) 2218 3280 or email [emailprotected]

SOURCE Chulalongkorn University

See original here:
When Blood Is a New Alternative Medicine for Pain Relief at Chula ... - PR Newswire